Monopar Therapeutics, Inc. (MNPR)
75.82
-1.23
(-1.60%)
USD |
NASDAQ |
Dec 12, 10:46
Monopar Therapeutics EPS Diluted (Quarterly): -0.4826 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| iRhythm Technologies, Inc. | -0.162 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Electromed, Inc. | 0.246 |
| Xtant Medical Holdings, Inc. | 0.0087 |
| VolitionRX Ltd. | -0.0497 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.438M |
| Total Expenses (Quarterly) | 3.438M |
| Enterprise Value | 371.29M |
| Earnings Yield | -4.54% |
| Normalized Earnings Yield | -4.536 |